Table 1.
Demographics
| Total (n = 205) | Group by ESAS |
|||
|---|---|---|---|---|
| Evaluated (n = 57) | Not-evaluated (n = 148) | p | ||
| Age (years) | 60 (IQR: 53.0–69.0) | 60 (IQR:52.8–69.5) | 59 (IQR: 53.0–68.5) | 0.699 |
| Sex (F:M) | 96:109 (46.8%:53.2%) | 25:32 (43.9%:56.1%) | 71:77 (48.0%:52.0%) | 0.709 |
| Primary site of cancer | 0.840 | |||
| Hepato-biliary-pancreatic | 72 (35.1%) | 17 (29.8%) | 55 (37.2%) | |
| Gastrointestinal | 42 (20.5%) | 12 (21.1%) | 30 (20.3%) | |
| Lung | 28 (13.7%) | 9 (15.8%) | 19 (12.8%) | |
| Gynecologic | 16 (7.8%) | 4 (7.0%) | 12 (8.1%) | |
| Genito-urinary | 13 (6.3%) | 5 (8.8%) | 8 (5.4%) | |
| Head and neck | 5 (2.4%) | 1 (1.8%) | 4 (2.7%) | |
| Brain | 5 (2.4%) | 1 (1.8%) | 4 (2.7%) | |
| Skin | 4 (2.0%) | 2 (3.5%) | 2 (1.4%) | |
| Breast | 3 (1.5%) | 1 (1.8%) | 2 (1.4%) | |
| Orthopedic | 1 (0.5%) | 1 (1.8%) | 0 (0%) | |
| Others | 16 (7.8%) | 4 (7.0%) | 12 (8.1%) | |
| ECOG Performance Status | 0.926 | |||
| 0 | 2 (1%) | 1 (1.8%) | 1 (0.7%) | |
| 1 | 57 (27.8%) | 13 (22.8%) | 44 (29.7%) | |
| 2 | 65 (31.7%) | 22 (38.6%) | 43 (29.1%) | |
| 3 | 43 (21.0%) | 12 (21.1%) | 31 (20.9%) | |
| 4 | 37 (18.0%) | 9 (15.8%) | 28 (18.9%) | |
| Missing | 1 (0.5%) | 0 | 1 (0.7%) | |
| Route of APCU admission | 0.146 | |||
| Outpatient clinic | 84 (41.0%) | 28 (49.1%) | 56 (37.8%) | |
| Emergency room | 23 (11.2%) | 3 (5.3%) | 20 (13.5%) | |
| Inpatient clinic | 98 (47.8%) | 26 (45.6%) | 72 (48.6%) | |
| Source of referral for APCU admission | 0.575 | |||
| Oncology | 166 (81.0%) | 46 (80.7%) | 120 (81.1%) | |
| Internal medicine | 13 (6.3%) | 2 (3.5%) | 11 (7.4%) | |
| Urology | 9 (4.4%) | 3 (5.3%) | 6 (4.1%) | |
| Neurosurgery/Neurology | 6 (2.9%) | 3 (5.3%) | 3 (2.0%) | |
| General surgery | 4 (2.0%) | 1 (1.8%) | 3 (2.0%) | |
| Obstetrics/Gynecology | 3 (1.5%) | 0 (0%) | 3 (2.0%) | |
| Others | 4 (2.0%) | 2 (3.5%) | 2 (1.4%) | |
| Reason for APCU admissiona | ||||
| Symptom control | 193 (94.1%) | 55 (96.5%) | 138 (93.2%) | 0.517 |
| Terminal care | 59 (28.8%) | 9 (15.8%) | 50 (33.8%) | 0.011 |
| Transitional care | 46 (22.4%) | 12 (21.1%) | 34 (23.0%) | 0.768 |
| Evaluation | 18 (8.8%) | 2 (3.5%) | 16 (10.8%) | 0.098 |
| For anticancer treatment | 2 (1.0%) | 1 (1.8%) | 1 (0.7%) | 0.480 |
| Anticancer treatment | 0.596 | |||
| Ongoing | 47(22.9%) | 15 (26.3%) | 32 (21.6%) | |
| Completed | 158(77.1%) | 42 (73.7%) | 116 (78.4%) | |
a
Numbers were duplicated per patients.
APCU, Acute palliative care unit; ECOG, Eastern Cooperative Oncology Group; ESAS, Edmonton Symptom Assessment Scale.